Small-cap stocks posted a blistering performance in the first half of this year. The Russell 2000 Index surged 22% through June, marking its strongest first-half performance since ...

The Russell Microcap Index has more than doubled the performance of the S&P 500 this year.

The S&P/ASX Small Ordinaries Index (XSO) finished slightly weaker yesterday, slipping 5.30 points, or 0.15%, to 3,434.50.

Strategists at Goldman Sachs said the three key catalysts for the Russell 2000’s recent outperformance were the artificial-intelligence industry, a strong economic backdrop and a boost in ...

The S&P/ASX Small Ordinaries Index (XSO) edged lower in the latest session, slipping 7.50 points, or 0.22%, to 3,424.90. The ...

Candel Therapeutics (CADL) shifts to late-stage oncology with CAN-2409 Phase III wins and BLA catalyst. Read here for a ...

The Russell Microcap Index has more than doubled the performance of the S&P 500 this year . Microcap stocks as a group have soared this year. That comes with ...

Fibonacci Retracements Explained: How to Spot Key Reversal Levels in 2026 A jump in 2026 earnings forecasts to 38% has brought institutional investors back into Russell 2000 stocks. Fed policy remains ...

Global merger activity reached a record $2.6 trillion in the first half of the year as companies pursued larger acquisitions, ...

Dow Jones Industrial Average futures were little changed early Tuesday after a record-setting session for the blue-chip index. Futures tied to the 30-stock index added 50 points, or around 0.1%. S&P ...

To find the latest Stock Market Today threads, click here. Happy Monday. Stocks were rising as tech stocks surged and oil ...

The Trump administration is proposing a new rule to keep hospitals from marking up discounted drugs for Medicare patients.